The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial ...
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible ...
Hosted on MSN
AI pathology system SPARK offers new cancer insights
Researchers at University Hospital Cologne have developed SPARK, an AI-based pathology framework that autonomously generates and refines biological hypotheses from tissue images. Tested on over 5,400 ...
Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer ...
Like all forms of cancer, lung cancer is defined by uncontrolled cell division caused by loss of physiological tissue homeostasis and failure of apoptotic cell death mechanisms. Aberrant cell ...
QIMR Berghofer researchers developed STimage, an AI-powered pathology tool that detects hidden cancer biomarkers in standard ...
The FDA has cleared ArteraAI Breast, the first digital pathology-based risk stratification tool for breast cancer. The AI software analyzes tumor tissue images and clinical data to categorize ...
Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results